Cited by 154Atrial Fibrillation Management and OutcomesHealth Systems, Economic Evaluations, Quality of LifeHealth Promotion and Cardiovascular Prevention

Cost-effectiveness of mass screening for untreated atrial fibrillation using intermittent ECG recording

Aronsson, Mattias, Svennberg, Emma, Rosenqvist, Mårten, Engdahl, Johan, Al-Khalili, Faris, Friberg, Leif, Frykman-Kull, Viveka, Levin, Lars-Åke·2015·Europace

Abstract

AIMS: The aim of this study was to estimate the cost-effectiveness of 2 weeks of intermittent screening for asymptomatic atrial fibrillation (AF) in 75/76-year-old individuals. METHODS AND RESULTS: The cost-effectiveness analysis of screening in 75-year-old individuals was based on a lifelong decision analytic Markov model. In this model, 1000 hypothetical individuals, who matched the population of the STROKESTOP study, were simulated. The population was analysed for different parameters such as prevalence, AF status, treatment with oral anticoagulation, stroke risk, utility, and costs. In the base-case scenario, screening of 1000 individuals resulted in 263 fewer patient-years with undetected AF. This implies eight fewer strokes, 11 more life-years, and 12 more quality-adjusted life years (QALYs) per 1000 screened individuals. The screening implies an incremental cost of €50 012, resulting in a cost of €4313 per gained QALY and €6583 per avoided stroke. CONCLUSIONS: With the use of a decision analytic simulation model, it has been shown that screening for asymptomatic AF in 75/76-year-old individuals is cost-effective.

Integrity signals

Registry

Crossref · 10.1093/europace/euv083

Cites

48 of 48 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Aronsson, M., Svennberg, E., Rosenqvist, M., Engdahl, J., Al-Khalili, F., Friberg, L., Frykman-Kull, V., & Levin, L.-Å.
Affiliations
  • Linköping University (SE)
  • Danderyds sjukhus (SE)
  • Hallands sjukhus Halmstad (SE)
Corresponding author
Aronsson, Mattias
Venue
Europace
Published
2015-04-12
Volume
17
Issue
7
Pages
1023-1029
ISSN
  • 1099-5129 (ISSN-L)
  • 1532-2092
OpenAlex
W2160206914
Cited by
154
References
48
Citations by year
2026: 2 · 2025: 8 · 2024: 7 · 2023: 9 · 2022: 13 · 2021: 21 · 2020: 15 · 2019: 28 · 2018: 14 · 2017: 16 · 2016: 19 · 2015: 2
FWCI
12.36
Type
journal article
Language
en
Open access
closed
Locations
  • EP Europace (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
  • Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Health Promotion and Cardiovascular Prevention
Keywords
atrial fibrillation, mass screening, asymptomatic atrial fibrillation, cost-effectiveness, older adults, stroke prevention, oral anticoagulation, quality-adjusted life years
MeSH terms
Aged, Atrial Fibrillation, Cost-Benefit Analysis, Electrocardiography, Female, Humans, Male, Mass Screening, Quality of Life, Sweden, Prevalence, Survival Rate, Health Care Costs, Risk Assessment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review